Health Archive » January, 2022

Health - January, 2022

428 articles

• Opioid Pills Set Off 'Triple Wave' Of Addiction, Judge Hears
• 9th Circ. Won't Review DEA Letter On Medical Psilocybin Use
• UK Bill Would Waive IP On Pandemic Vaccines, Treatments
• NJ Justices Challenge Broad View Of Expert Affidavit Rule
• ICE Detainees Seek Booster Shots For Medically Vulnerable
• Elite Trial Lawyer Switches Sides To A Changing Plaintiffs Bar
• Feds Tell Jury Ex-Drug Co-Op CEO To Blame For Opioid Crisis
• Moderna COVID-19 Vaccine Gets FDA's Full OK
• 3rd Circ. Revives Claims Against Nurse Over Patient's Assault
• Pharmacies Can't Get 6th Circ. Review In Ohio Opioid Trial
• A Comparison Of High Court Rulings On Vaccine Mandates
• Health Care Software Co. Says Rival Poached Workers, Data
• DaVita Can't Duck Criminal Antitrust Suit Over No Poach Deals
• Nursing Home Tells 5th Circ. COVID Suit Belongs In Fed. Court
• Castlight Health Investor Sues Over $370M Vera Sale
• Keys To Keeping Law Firm Talent Amid The Great Resignation
• Cardinal Health Pays $13M To Settle Doctor Kickback Claims
• Investors In Pot Co. Aphria Seek Class Cert. In $144M Suit
• Medtronic Accused Of Stealing Rival's Sales Reps, Customers
• Diversified Healthcare Trust Inks $703M JV For Office Portfolio
• Health Care Group Of The Year: Morgan Lewis
• Insurers, WTA Reach Deal Over $10M Blood Test Arbitration
• Medical Imaging CEO Gets 5 Years In Prison For $250M Fraud
• Feds Snag Win In Tribal Challenge To COVID Fund Distribution
• CVS Drug Buyers Ask 9th Circ. For Redo Of $121M Trial
• Property Insurance Not For Virus Losses, Trade Group Argues
• DOL Says Employers Struggling With Mental Health Parity Law
• Drugmakers Won't Get Discovery From Valisure In Zantac MDL
• Cannabis Bill Roundup: SAFE Banking Gets Another Shot
• Purdue's Appeal On Ch. 11 Releases Fast-Tracked By 2nd Circ.
• Feds Say Health Care Execs Fixed Wages Amid Pandemic
• Lab Owners Aim To Duck $24M Medicaid Overpayment Claims
• Texas Justices Will Review $10.3M Cerebral Palsy Birth Verdict
• Immigration Policy Changes Are A Boon To STEM Employers
• Arizona Judge Is Latest To Block Contractor Vax Mandate
• Health Hires: Manatt, Garfunkel Wild
• Ex-CDC Worker's Bias Suit Should Get Spiked, Judge Says
• Pa. Worker Claims He Was Fired For Medical Pot Use
• Alston & Bird Nabs Former FDA Associate Chief Counsel
• Ga. County Joins Fight Over In-Network Health Insurance
• Health Care Group Of The Year: McDermott
• Strategies For Coping With Stress In The Legal Profession
• How Employers Can Determine COVID Test Mandate Costs
• Sichenzia Ross, Loeb Lead $2.5B Health Care Tech SPAC Deal
• 4 Highlights In Breyer's Legal Legacy For Health, Life Sciences
• 6 Breyer Product, Personal Injury Opinions Attys Should Know
• Judge Says Shkreli's Picasso Can Be Sold To Pay $2.6M Debt
• The Term: Breyer's Legacy And The Nomination To Come
• Fla. Judge Gives Cancer Patients Win Against Aetna
• Breyer Retiring As Supreme Court Lurches Right
• 3 Keys To Success For Health Care Private Equity Buyers
• 'Street Level' Oxy Pusher Admits Tricking Ex-CEO's Company
• All Pa. Counties Join $26B Opioid Deal Over DAs' Objections
• Vision Biz To Pay $3.5M For Violating Contact Lens Rule
• Offit Kurman Welcomes Health Care Atty To Harrisburg Office
• AGs Ask OSHA For Climate Change Heat Standards
• Ex-V&E Gov't Contracts Vice Chair Jumps To McDermott
• Impact Healthcare REIT Seeks To Raise $67M With Share Sale
• What You Need To Know About Judge Jackson
• Biden At His Side, Justice Breyer Announces Retirement
• 7th Circ. Dismisses Indiana Univ. Students' Vax Mandate Suit
• Democrats Plan Swift Confirmation Of Breyer Successor
• 4th Circ. Backs Toss Of FCA Medicaid Suit Against Allergan
• UHS Investors Get $2.5M Fees After 'Audacious' $5.7M Bid
• Mississippi Lawmakers Send Medical Pot Bill To Governor
• Meet The Possible Nominees For Justice Breyer's Seat
• Texas Gov. Asks State Justices To Affirm Mask Mandate Ban
• How AI Can Transform Crisis Management In Litigation
• OSHA Case Shows Fluidity Of Major Questions Doctrine
• Litigation Complicates Surprise Medical Bill Law Compliance
• 'Just Do Your Job': Justice Breyer's Legacy Of Pragmatism
• Ga. Health Care System Can't Shake $4.6M ERISA Class Action
• Blank Rome Adds Corporate Litigation Partner In Philly
• Tribal Corp. IP Suit Highlights Sponsored Research Pitfalls
• 5 Breyer Opinions You Need To Know
• Justice Breyer To Retire From High Court
• Kirkland-Led GTCR Clinches $2B Strategic Growth Fund
• 'Frankly Stunning': Distributors Pan DEA Vet At Opioid Trial
• NY Court Reporters Challenge Courthouse Vax Mandate
• Mass. Court Upholds Doc's Win In Spinal Surgery Suit
• Two Investor Settlements From 2021 Crack Top 100 List
• How Vaccine Mandates Impact Employment Insurance Policies
• Mallinckrodt, Fresenius Reach $14M Deal On Supply Claims
• Fla. Hospital Chain Must Face Part Of Antitrust Lawsuit
• Rhode Island Inks $91M Opioid Deal With Distributors
• The Insys Case Made History. Why An Exec's Appeal May Not
• Aliera Ch. 11 Cases To Be Consolidated In Del. Court
• Supervisor Relationships Are Key To Beating Atty Burnout
• Rite Aid Investors, Walgreens Ask To Slim Or Toss Merger Suit
• Texas Nursing Home Can't Dodge COVID Wrongful Death Suit
• Supplement Biz Says Rival Lies About Toxic Ingredients
• Texas Panel Sends $19M Reimbursement Case To Mediation
• Texas Hospital Can't Escape Pancreatitis Death Suit
• Health Care And Corporate Atty Joins Epstein Becker
• Distributor Urges 6th Circ. To Revive Opioid Coverage Suits
• Beyond Big: Smaller, Hyperfocused Firms Still Stand Out
• Drug Distributors' Order Reporting Had Flaws, Expert Testifies
• Inovio Fights Investor Class Cert. In COVID-19 Vaccine Suit
• NJ Court Revives Patient's Suit Over Botched Dental Implants
• 1st Circ. Affirms Broad Gov't Power To End FCA Suits
• Universal Health Says Chancery Class Suit Makes 'No Sense'
• Pharma Cos. Get Bystolic Generic Delay Claims Tossed
• Lionbridge Defeats TransPerfect's Trade Secrets Suit
• Ex-Compliance Boss Walks Fine Line At Oxy Conspiracy Trial
• USC Must Face Insurer's Bid To Rescind Excess Policy
• High Court To Skip Post-Firing Retaliation Fight In FCA Case
• UnitedHealth Files 2nd Suit Over $38M Merger Math Dispute
• Greenberg Traurig Adds Health Care Litigation Atty In NJ
• COVID Fuels Top Firms' Priorities In 2022
• The Leaderboard: Tracking A Firm's Litigation Footprint
• Meta, Snap's 'Addictive' Platforms Blamed For Child's Suicide
• Texas Judge Blocks Vaccine Mandate For Federal Workers
• Punitive Damages Give Cancer Survivor $10M Win Over RJR
• 9th Circ. Breathes New Life Into $50M Suit Against 49 Insurers
• Ga. Judge Grapples With Pot's Legal Status In Licensing Fight
• District Court Won't Hear J&J Talc Unit's Ch. 11 Stay Fight
• $26B Deal Keeps Opioid Files Of J&J, Distributors Out Of View
• Fla. Hospital Faces New Trial In Amputee's Recalled Drug Suit
• DOJ Sues Pharmacist For Filling Illegal Opioid Prescriptions
• 'Data-Rich' Sources Can ID Niaspan Class, 3rd Circ. Told
• Feds Say Nursing Home Owner Dodged $29.5M Payroll Tax Bill
• Lessons From Moderna's COVID Vaccine Patent Dispute
• Iowa Justices Order New Trial For Med Mal Stroke Suit
• Ariz. Oral Surgeon Escapes Suit Over Dental Implant Surgery
• Texas Justices Will Review Abortion Law Challenge
• Paul Hastings Expands DC Life Sciences Consulting Group
• 9th Circ. Says COVID Gun Shop Closures Defied Constitution
• Bill Paxton's Family Can Seek Punitive Damages From Cedars
• Okla. Law Firm Says Employee's Pot Licenses Suit Is A Dud
• EPA Says Fuel Importer Violated Clean Air Act
• Health Co. Gets ERISA Suit Booted To Arbitration
• Feds Urge High Court To Back Doctors' Opioid Convictions
• Covid Tester Escalates BCBS Pay Fight With Antitrust Claims
• Sutter Judge 'Optimistic' Virus Won't Further Delay Jury Trial
• Justices Again Decline To Streamline Texas Abortion Suit
• Clinical Trial Staffer Gets 30 Months For Research Fraud
• Real Estate Rumors: Wells Fargo, SL Green, Ram Realty
• Hemp Group Tells DC Circ. To Keep DEA Hands Off 'Hot' Crops
• GAO Unclear If HHS Is Prepared For Full COVID Vax Duties
• Alsup Mulls $113M Atty Fees In $454M Glumetza Antitrust Deal
• Drug Patent Suits' Novel Theory Tests False Claims Act Limits
• Investors Say Biotech Co. Altered Alzheimer Drug Data
• Latham, Davis Polk Guide Psychedelic Co.'s SPAC Merger
• HCA Monopolizes Orthopedic Surgeries In Florida, Suit Says
• Venture Wants Atty Fees Over CBD Cream Patent Row
• Fitness Center Asks 9th Circ. To Revive Virus Coverage Suit
• Insurer Wants Refund From Hawaiian Hospital For Abuse Suits
• 6 Maura Healey Cases To Know As Gov. Campaign Launches
• Pair Of Docs Must Pay $1M Over Misdiagnosed Ankle Break
• How Health Cos. Have Responded To Anti-Kickback Reform
• DaVita Tells Justices Not To Touch Win In Reimbursement Row
• 3rd Circ. Skeptical Of Reviving ERISA Row Over Asbestos In J&J Powder
• Smoking Was Bladder Cancer Patient's Choice, RJR Tells Jury
• Biden Seeks To Expel Migrant Families; DC Circ. Is Skeptical
• Starbucks Nixes Vax Rule After High Court Sinks OSHA Order
• Mississippi House Passes Medical Marijuana Legalization Bill
• Sanofi Tells 10th Circ. It Paid $36M To Access EpiPen Market
• Emails In Ex-CEO's Oxy Trial Cut Both Ways On Compliance
• The Hottest FCA Cases And Trends To Watch In 2022
• Access Bio Accused Of Breaching $120M COVID Test Kit Deal
• Drugmakers Want Discovery From Valisure In Zantac MDL
• Ill. COVID-19 Testing Cos. Falsified Results, Minn. AG Says
• Health Co. Can't Get 6th Circ. To Shut Down ACA Bias Suit
• School Nurse No-Poach Criminal Trial Moved To July
• Kaiser Says First-To-File Bar Breaks $1B Medicare Fraud Suits
• Ga. Hospital Seeks Dismissal Of 'Patient Dumping' Claims
• FTC Cracks Down On COVID Ad Claims Amid Omicron Surge
• Full Dallas Appeals Court Mulls Arbitration For Serial Killings
• The Rising Demand For Commercial Litigators In 2022
• Firms Seek $12M For $45M Surgery Partners Suit Settlement
• Cincinnati Fights New Evidence In Ohio High Court COVID Suit
• Canadian Model Wants $50M Allergan Unit Suit To Proceed
• Venable Adds 7 DC Health Care Experts From Faegre Drinker
• NJ Bankruptcy Judge Undoes Split Of J&J Tort Committee
• Parents Can Amend Suit Over Fla. COVID-19 School Rules Ban
• Marketer Says Racial Bias Drove Pa. Lab's Contract Breach
• No New Trial For Smith & Nephew Hip Implant Patient
• Boston Children's Retirement Plan Too Pricey, Suit Says
• Purdue Urges 2nd Circ. To Quickly Undo Ch. 11 Plan Rejection
• Pharma Biz Lied About COVID-19 Drug's Prospects, Suit Says
• ​​​​​​​Justices Call Solicitor General Into Fraud Standards Case
• Justices Turn Down NC Health Plan Transition Coverage Battle
• Justices Asked Not To Review Medical Pot Reimbursements
• Endo's Newest Opioid Deal Earmarks $65M For Fla.
• Sutter Calls Class' Bid For Chief Judge Intervention 'Improper'
• Florida Seeks End To Suit Over COVID-19 School Rules Ban
• Tyson Can't Escape COVID-19 Mandate Suit, Workers Say
• Tribe Says Its Opioid Suit Was Not Harmed By Dropped Claim
• Pharma Co. Gets Partial Win In Cancer Drug Contract Fight
• Reps. Float Bipartisan Bill To Improve Native American Health
• Antitrust's 1900s Nostalgia In The US And Beyond
• Cancer Nonprofit Exec Embezzled $3.7M, Feds Say
• Trade Group Turns To High Court In Seattle Benefits Law Fight
• Unvaccinated Ex-Aegerion Rep Can't Delay 4-Year Fraud Term
• Ex-CEO's Atty Blasts Feds' 'Sales Over Safety' Oxy Charges
• DOD Says Navy Vax Challengers Jumped Gun On Lawsuit
• Fla. Hospital Worker Gets $4M In T-Bone Accident Suit
• 9th Circ. Revives $8.6M Reimbursement Suit Against Cigna
• 5th Circ. Punts Abortion Challenge To Texas Supreme Court
• Akerman Appeals Counsel DQ In Medicare Repayment Row
• Teligent's 3 Ch. 11 Asset Sales Bring $87M Into Estate
• Norton Rose Avoids DQ In $340M COVID Coverage Suit In NY
• Teva, Glenmark Must Face Price-Fixing Suit At Same Trial
• 3 Firms Rep ProKidney's $2.64B Go-Public SPAC Deal
• Law360 Names Practice Groups Of The Year
• The Firms That Dominated In 2021
• 5 Questions After High Court Smacks Down Vax-Or-Test Rule
• Pharma Exec's Drug Trafficking Trial Tests Bold Legal Theory
• Judge Gives J&J Talc Unit's Ch. 11 Dismissal Bid Prominence
• War Exclusion Doesn't Bar Merck's $1.4B Cyber Loss
• Justices To Rule If Cops Can Be Sued For Miranda Violations
• Full Fed. Circ. Won't Revive Juno's $1.2B Cancer Patent Win
• Justices Correctly Used Shadow Docket In OSHA Vax Ruling
• Insys Founder Challenges Opioid Conviction At High Court
• Nebraska Sues County Health Official Over Mask Mandate
• Nursing Home Chain Wants To Trim $40M Bond Debt In Ch. 11
• Medical Practice Says Union Owes $576K For COVID-19 Tests
• Delaware Suit Means SPACs Will Face Tougher Legal Scrutiny
• Patients Can't Yet Score Win In UBH Surprise Billing Suit
• Orphan Drug Approval Takeaways From Recent FDA Data
• 'Pharma Bro No More' Shkreli Gets Industry Ban, To Pay $65M
• 3 Firms Guide Pair Of Tech-Focused SPACs Raising $511M
• Hospital Workers Target Fees Paid By $10B Retirement Plan
• What High Court Rulings Mean For Employer Vax Mandates
• Health Hires: Manatt, Oscar Health
• 5 Firms To Guide Eye Care Giant Bausch & Lomb's IPO Spinoff
• 'Horror Story' Logjam Will Bump Panasonic Trial, Judge Says
• Texas Physician, Hospital Must Face Patient Infection Suit
• IHS Finalizes Rule To Improve Buy Indian Act Implementation
• 'Someone Is Going To Get Sick': Sutter Judge Eyes Later Trial
• Boca Lab Owner Admits To $6.9M Medical Testing Scheme
• Mississippi Senate Advances Medical Pot Legalization Bill
• Texas AG Says Planned Parenthood Owes $10M
• Creditors Say Aliera Ch. 11 Needs To Stay In Delaware Court
• Health Care Co. Seeks Stay Of FCA Suit For High Court Appeal
• Attys Want $12M After Perrigo Tax Bill Settlement
• COVID 'Long Hauler' Says Disability Claim Wrongly Denied
• Glenmark's Ethics Allegations Against DOJ Rejected
• 5th Circ. Partially Revives Asbestos Suit Against Boeing
• NM Eye Practice's Virus Coverage Suit Survives Dismissal Bid
• How In-House Counsel Can Make The Case For Settling Early
• 2nd Circ. Rejects Biotech Investor's Media Defamation Suit
• Justices Sink Vax-Or-Test Rule But Clear Health Care Mandate
• Worker Says Wells Fargo Scared Her Out Of COBRA Coverage
• Sens. Move Forward Nominees For FDA Chief, Labor Dept.
• Court OKs Pharma Investors' $12.7M Deal Over Drug Trial
• NY Hospital, Physicians Must Face Amputee's Gangrene Suit
• Pandemic Put Deep Freeze On State Trials, New Data Show
• Cannabis Biopharma Co. Nabs CLO From Suboxone Maker
• 13 People Charged Over Alleged 'No-Fault' Insurance Crimes
• 2 Former Federal Prosecutors Head To BakerHostetler
• 8th Circ. Mulls Virus Exclusion COVID-19 Coverage Suit
• 7th Circ. May Hold Ind. Abortion Row For High Court Ruling
• Indian Health Service Must Face Patient's Sex Assault Suit
• Clinical Trial Co. Owner Admits Lying To FDA
• NY, NJ Health Centers Reach $7.5M Deal To End FCA Claims
• Ky. Dentist's COVID Coverage Loss Upheld By 6th Circ.
• To Retain Talent, GCs Should Prioritize Mission Statements
• How Health Cos. Can Minimize Consolidation Risk
• UnitedHealth Unit's Class Cert. Appeal Is Bunk, 7th Circ. Told
• Walgreens Sued Over 'Maximum Strength' Pain Relief Claims
• Quebec Plans Tax For Residents Who Don't Get COVID Vax
• Sutter Antitrust Trial Must Go On Despite COVID, Judge Told
• Judge Says Soldiers Should Seek Vax Waiver, Not Sue
• Cooley, Loeb & Loeb Shape $511M Medical Co. SPAC Merger
• Investment Firm Founder Asks 4th Circ. To Reinstate $8M Win
• What Attys Can Learn From Harvard Professor's Conviction
• Ex-Theranos CEO Elizabeth Holmes To Be Sentenced Sept. 26
• CMS Wants Narrow Coverage For Biogen's Alzheimer's Drug
• Sotomayor, Breyer Scrutinized In Feisty Senate COVID Hearing
• 7th Circ. Won't Resurrect Ill. Churches' COVID Closure Suit
• US Warns Of Russian Cyberattacks On Critical Infrastructure
• Ga. Justices Won't Touch Default Loss In Atty Malpractice Suit
• Omicron COVID Variant Is 'Relatively Mild,' Says Panasonic
• Cherokees Drop 'Public Nuisance' Theory In Opioid Bellwether
• Delaware AG Sues Over Seaford Abortion Ordinance
• Health Care Policy Priorities To Watch In 2022
• Judge Won't Lift Ch. 11 Injunction For J&J Talc Claims
• Dallas Courts Issue Delays Amid COVID Spike
• Gym Franchisees Tell 4th Circ. To Revive Virus Coverage Suit
• McKinsey Deal Not Enough For Opioid Costs, Mass. Suit Says
• Engineering Co. Still Faces Flint Water Study Claims At Trial
• 9th Circ. Skeptical Of Coverage For Co.'s Opioid Probe Costs
• Mich. Health Care Group Strikes $3M Deal In ERISA Suit
• Health Insurer Wants Delaware Ch. 11 Case Moved To Georgia
• Top 10 Whistleblowing And Retaliation Events Of 2021
• Punitive Damages Nixed From $10.5M Medical Sponge Verdict
• JPMorgan Exec Says Prudential Cut Benefits After Car Crash
• K&S Adds Former DOJ Litigator To Health Care Practice
• Boston Hospital Workers Urge 1st Circ. To Block Vax Mandate
• 5th Circ. Blasts Court For Sealing Records In Abortion Case
• GoodRx Beats IPO Suit Over Surprise Amazon Competition
• Biden Orders Health Insurers To Cover At-Home COVID Tests
• SPAC Investor Says Talkspace Misled On Costs, Demand
• Justices Told Fla. Can't Claim Part Of Injury Settlement
• Utah Pot Licensing Suit More Than Adequate, Court Told
• LAPD Workers' COVID-19 Vax Mandate Challenge Tossed
• Health System's Virus Coverage Suit Sent Back To State Court
• Calif. AG Clears Split Of Health Systems With Commitments
• Calif. Gov. Would Restore NOLs, Biz Credits In Budget
• NJ Legislature Passes Bill To Guarantee Right To Abortion
• Regeneron Wins Access To FDA Docs In Kickback Suit
• Ill. Panel Lets Medical Group Out Of Cardiac Negligence Suit
• KKR Clinches $4B Health Care Growth Equity Fund
• High Court Won't Hear Off-Label Ad Suit Against Taro
• Chancery Rejects Fast-Tracking Of $6.7B Arena Merger Suit
• Kirkland, Simpson Thacher Rep $1.45B Owens & Minor Deal
• Kirkland, Ropes & Gray Rep R1's $4B Cloudmed Buy
• Justices Pass On Alarm Co. Worker's FMLA Retaliation Case
• Pa. Panel Restores Psychiatric Records' Privilege In Birth Suit
• Dykema Opens Milwaukee Office With Capital Markets Laterals
• Calif. Gov. Signs Order Barring COVID Test Price-Gouging
• Duane Morris, Sidley Steer Four Springs' $252M IPO Launch
• Decision Delayed On Whether Talc Spinoff Stay Shelters J&J
• High Court Won't Revive Pa. COVID-19 Restrictions Suit
• Harvard Won't Have To Pay Prof's Legal Tab In China Case
• Justices To Review Nuclear Workers' Comp. Law
• Ex-Theranos COO May Face Trial Delay Due To COVID Surge
• 11th Circ. Won't Rehear Catalyst's Win In 'Orphan Drug' Case
• 5th Circ. Mulls Punting Texas Abortion Fight To State Court
• Cannabis Bill Roundup: Lawmakers Kick Off 2022 Sessions
• 'You Can't Kill Patients': Justices Open To CMS Vaccine Rule
• How Attys For Long Island Counties Notched Opioid Trial Win
• Investors Sue Health Insurer Over COVID-Linked Costs
• Deals Attys Approach JPMorgan Event Cautiously Optimistic
• Up Next At High Court: Medicaid Clawback, Day-Late Tax Case
• Stockholder Sues To Block Pfizer's $6.7B Arena Pharma Buy
• Walgreens' Settlement History Will Stay Out Of SF Opioid Row
• The State Of FDA Regulation Of Software As A Medical Device
• Calif. Says Stopping Pay-For-Delay Ban Went 'Too Far'
• 3rd Circ. Affirms Pharmacy Owner's Tax Fraud Conviction
• NJ Judge Won't Recuse Herself From Nursing Home Suit
• Purdue Ch. 11 Appeal Can Go To 2nd Circ., NY Judge Rules
• FisherBroyles Adds Attys From Jones Day, Polsinelli
• Justices' Texas Abortion Ruling Is Murky On Key Question
• High Court Grapples With Impact Of Blocking Vax-Or-Test Rule
• Illumina Investor Sent To Prison During Insider Trading Appeal
• 8th Circ. Ruling Sets Road Map For Disability Benefit Reviews
• Generics Catch A Break With Hikma's Skinny Label Win
• Mallinckrodt Says Ch. 11 Plan Fair For Acthar Claimants
• Calif. Tax Plan Would Fund Single-Payer Health Care
• NJ Lawmakers Advance Bill To Enshrine Right To Abortion
• Texas Court Ends Patient's Fraud Suit Against Hospital
• Workplace Vaccine Rules Take Center Stage At High Court
• Ex-CEO Says Barnes & Thornburg Conflict Hurt His Defense
• A Tale Of Two Cases: Lessons In No-Poach Litigation
• Texas Gov. Loses Third Appeal Over Mask Mandate Ban
• Policyholder Attys Hail Wash. Justices' Entry Into Virus Fight
• Bipartisan Bill Would Give Tribes Access To Medical Stockpile
• 2nd Circ. Rips 3rd Circ. Over Faxed Survey TCPA Ruling
• Loeb & Loeb Hires White And Williams' Securities Group Chair
• States Oppose Purdue's 2nd Circ. Appeal Try In Ch. 11 Case
• Class Attys Get $20M From UnitedHealth ERISA Win
• Hawaiian Airlines Workers Sue To Block Vaccine Mandate
• Mylan Can't Exclude Ex-CEO From EpiPen Antitrust Trial
• Ex-Owners' Antitrust Claim Denied After Buyers Close Firm
• Del. Justices Toss SmileDirectClub Stockholder Deal Appeal
• ICE Watchdog Finds Medical Issues At Shuttered Ga. Facility
• How Congressional Oversight May Shift In 2022 And Beyond
• No DQ For NY Fed. Prosecutor In Opioid Case Against Ex-CEO
• Epstein Becker Adds To Health Care Group In Tenn., Ohio
• Inovalon Investors Seek Stock Appraisal After $7.3B Sale
• Recent Bias Suits Against Law Firms And Lessons For 2022
• Damages Award Nixed In Child's MMR Vaccine Injury Dispute
• Health Plan Servicers' Disclosure Rule Objections Are Faulty
• Skadden-Led Stryker Buys $3.09B Health Care Software Maker
• Split 6th Circ. Won't Stay Contractor Vax Mandate Injunction
• 5th Circ. Critical Of DOL In Data-For-Insurance ERISA Case
• Ex-DEA Official Says Cardinal 'Barely' Monitored For Opioids
• 9th Circ. Seeks Help In Wash. $10M Wrongful Birth Verdict
• Ohio Home Health Care Co. Settles FCA Case, Agrees To Close
• Stockholders Sue AmerisourceBergen In Del. Over Opioids
• Teva Urges Judge To Limit Walgreens, CVS Antitrust Claims
• DC Circ. Denies Texas Arg Time In Migrant Expulsion Suit
• Ex-Medical Debt Collector Execs Cop To $1.5B Ponzi Scheme
• $20M Acquisition Would End Maryland Pot Biz Feud
• Medicare Advantage Plans Must Beware DOJ Scrutiny
• Harter Secrest Nabs Ex-Vanderbilt Medical CCO As Partner
• Navy Vaccine Religious Exemption Ruling Warrants Scrutiny
• Garfunkel Wild Adds Ex-Health Tech GC As Partner
• Saul Ewing Arnstein & Lehr Adds Health Care Counsel
• Kirkland, Fenwick Guide $370M Vera-Castlight Merger
• 4 Takeaways From Elizabeth Holmes' Fraud Verdict
• Nevada Says It's Joining $26B Deal With Opioid Distributors
• Texas Abortion Providers Ask Justices To Speed Up SB 8 Suit
• Arizona Not Harmed By Vax Mandate, Biden Admin. Says
• No 'Safe Harbor' For Gene Therapy Found In Hatch-Waxman
• Cannabis Co. Trulieve Escapes Investors' Moldy Pot Suit
• Acthar Claimants Call Mallinckrodt's Ch. 11 Plan Unfair
• Opioid Claims Involving McKinsey Should Be Axed, States Say
• Labcorp To Provide Nursing-Mom Rooms After DOL Probe
• How To Navigate The Coming Antitrust Policy Tests
• Generic Drug Cos., Takeda Escape Gout Drug Antitrust Suit
• Ga. Judges Uphold 'Harsh' Sanction Against Dental Clinic
• Texas Sues Biden Admin. Over National Guard Vax Mandate
• Nimbus, Bristol-Myers Drop Psoriasis Drug Dispute
• DC Circ. Revives Terror-Funding Case Against AstraZeneca
• Merit Medical's $18.25M Investor Fraud Deal Gets First OK
• Walgreens Workers Attys Seek $4.6M In Sweeping ERISA Case
• NY Hospital Equipment Co. Settles DOL ERISA Probe
• GSK Ex-Worker Cops To Trade Secrets Theft
• Holland & Knight, Sidley Rep $340M Health Care Software Sale
• Boston Scientific Says Dead-End SEC Probe Sinks Stock Suit
• Purdue's 2nd Circ. Appeal Request To Get Quick Decision
• Judge Calls Navy's Religious Vax Exemption Process 'Theater'
• AdventHealth Settles DOJ Case Over Deaf Patient Care
• U. Of Chicago Prof Pleads Not Guilty To Insider Trading
• How The ERISA Landscape May Shift This Year
• 5th Circ. Questions Success Of United Vax Mandate Challenge
• Jury Convicts Ex-Theranos CEO Elizabeth Holmes Of Fraud
• Holmes Jury Tells Judge It's Deadlocked On 3 Of 11 Counts
• ERISA Cases To Keep An Eye On In 2022
• Bankruptcy Cases To Watch In 2022
• A Look At What's Ahead For Antitrust Enforcement In 2022
• Associate Hiring Outlook At Law Firms Is Bright For 2022
• Merger Cases, Issues To Watch In 2022
• Florida Legislation To Watch In 2022
• The Antitrust Conduct Cases To Watch In 2022
• High Court To Scrutinize Vaccine Rules As 2022 Kicks Off
• A Blockbuster Year Ahead For Health, Life Sciences Litigation
• Buckle Up: Wild Ride Awaits Health, Life Sci Policy In 2022
• Texas Cases To Watch In 2022
• Product Liability Regulation, Legislation To Watch: 2021
• 'Remain In Mexico' Renewal May Bring More Solo Migrant Kids
• Cybersecurity & Privacy Cases To Watch In 2022
• 2022 Trials To Watch: Opioids, Oracle And Theranos Redux
• Personal Injury And Med Mal Cases To Watch In 2022
• Product Liability Cases To Watch In 2022